QRG Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$654K Buy
11,131
+156
+1% +$6.54K 0.01% 775
2026
Q1
$354K Sell
10,975
-28,295
-72% -$1.05M ﹤0.01% 893
2025
Q4
$1.65M Buy
39,270
+3,567
+10% +$144K 0.02% 446
2025
Q3
$1.23M Sell
35,703
-106,926
-75% -$3.07M 0.01% 485
2025
Q2
$3.86M Buy
142,629
+3,297
+2% +$95.5K 0.03% 356
2025
Q1
$4.13M Sell
139,332
-318
-0.2% -$12.1K 0.04% 333
2024
Q4
$5.53M Buy
139,650
+4,834
+4% +$183K 0.06% 272
2024
Q3
$4.59M Buy
134,816
+5,400
+4% +$152K 0.05% 292
2024
Q2
$2.8M Buy
129,416
+4,015
+3% +$84.4K 0.03% 356
2024
Q1
$2.78M Sell
125,401
-8,484
-6% -$207K 0.04% 353
2023
Q4
$3.68M Buy
133,885
+6,583
+5% +$159K 0.05% 310
2023
Q3
$2.84M Buy
+127,302
New +$3.27M 0.05% 318

Other funds holding VCYT

QRG Capital Management's VCYT Position: Q2 2026 in Review

QRG Capital Management increased its Veracyte (VCYT) stake by 1.4% in Q2 2026, buying an estimated $6.54K and bringing the position to 11,131 shares worth $654K. The position accounts for 0.01% of the portfolio, ranked #775.

QRG Capital Management first reported a position in VCYT in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.53M in Q4 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • QRG Capital Management held 11,131 shares of Veracyte worth $654K as of Q2 2026.
  • QRG Capital Management bought 156 Veracyte shares in Q2 2026, an estimated $6.54K.
  • Veracyte made up 0.01% of QRG Capital Management's portfolio in Q2 2026, its #775 holding.
  • QRG Capital Management first reported a position in Veracyte in Q3 2023 and has held it in 12 quarters since.
  • QRG Capital Management's Veracyte position peaked at $5.53M in Q4 2024.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.